MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Healthcare Real Estate: Responding to Shifting Patient Demands
To compete in a changing landscape, healthcare organizations must turn their real estate from a cost center into a competitive advantage.
Over 40% of Workers Impacted by Seasonal Depression
Seasonal changes can have an impact on work performance.
Archer Property Partners Acquires Medical Office Building Near Tri-City Hospital
Archer plans a $2.5 million capital improvement program to fully modernize and reposition the asset as one of North County’s premier medical office destinations.
The OR HVAC Puzzle: Why Individual Systems Are on the Rise
Extra penetrations, tight clearances and strict humidity needs—design experts explain what it really takes to plan dedicated units for each operating room.
Sutter Health Announces Plans for New Santa Clara Medical Center
Sutter projects the medical center will open in late 2031.